World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02216565
Date of registration: 13/08/2014
Prospective Registration: Yes
Primary sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Public title: Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase EASY
Scientific title: Benefits of the Endovascular Treatment in the Early Management of Proximal Sylvian Artery Thrombosis in Patients Refractory or Ineligible to Intravenous Fibrinolysis : a Multicenter Controled Randomized Trial
Date of first enrolment: December 1, 2014
Target sample size: 2
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT02216565
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Michel Piotin, MD
Address: 
Telephone:
Email:
Affiliation:  Fondation Ophtalmologique Adolphe de Rothschild, Paris
Name:     Marc-Antoine Labeyrie, MD
Address: 
Telephone:
Email:
Affiliation:  Hopital Lariboisiere, Paris
Key inclusion & exclusion criteria

Inclusion Criteria:

- Radiologically proven acute proximal occlusion of middle cerebral artery

AND one of the three following :

1. tandem internal carotid / middle cerebral artery occlusion

2. intravenous thrombolysis contraindicated because of high risk of haemorrhage

3. intravenous thrombolysis not possible because of delay > 4.5 hours

Exclusion Criteria:

- Impossibility to perform endovascular recanalization within 6h

- Clinically minor stroke (NIHSS score below 5 at baseline)

- Extended cerebral infarction

- Severe comorbidity

- Life expectancy below 3 months before stroke

- Pregnancy or breastfeeding

- modified Rankin Score superior to 2 before stroke



Age minimum: 18 Years
Age maximum: 82 Years
Gender: All
Health Condition(s) or Problem(s) studied
Stroke, Acute
Intervention(s)
Other: Supportive care
Other: Hospitalization in specialized neuro-vascular unit
Procedure: Endovascular treatment
Drug: Alteplase if patient is eligible
Primary Outcome(s)
Improvement in NIHSS score after 24h [Time Frame: 24 hours]
Secondary Outcome(s)
Fatality within 3 months [Time Frame: 3 months]
Fatality within 7 days [Time Frame: 7 days]
Improvement in NIHSS score after 7 days [Time Frame: 7 days]
Functional recovery after 3 months [Time Frame: 3 months]
Secondary ID(s)
2014-A00519-38
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history